Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

Clinical trial NCT05744687 · RECRUITING

Trial details

NCT number: NCT05744687
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Breast Cancer

Start date: 2023-04-24
Primary completion: 2026-05-31
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.